Semler Scientific, a healthcare technology company, has set an ambitious goal to accumulate 105,000 Bitcoins by the end of 2027. This target, announced alongside the appointment of Joe Burnett as the Director of Bitcoin Strategy, signifies a major commitment to Bitcoin as its primary treasury reserve asset. The company plans to reach this goal by strategically utilizing proceeds from equity and debt financing, as well as cash flow from operations.
This aggressive accumulation strategy involves specific targets for the coming years. Semler aims to hold 10,000 Bitcoins by the end of 2025 and increase its holdings to 42,000 by the end of 2026, before reaching the 105,000 Bitcoin mark by the end of 2027.
The company's focus on Bitcoin began in May 2024, making it the second U.S. publicly traded company to adopt Bitcoin as a primary treasury reserve asset, following MicroStrategy. Semler Scientific's board of directors believes that Bitcoin's scarcity, finite supply, and potential as an inflation hedge make it a compelling long-term investment. By allocating a significant portion of its treasury to Bitcoin, the company aims to protect shareholder value against currency devaluation and global economic instability.
As of early June 2025, Semler Scientific held 4,449 Bitcoins, acquired for approximately $410 million at an average price of $92,158 per Bitcoin. These holdings were valued at around $446.2 million at the time. The company has been actively increasing its Bitcoin holdings through a series of purchases, funded by proceeds from its at-the-market (ATM) equity offering and other financing methods.
Joe Burnett, the newly appointed Director of Bitcoin Strategy, brings significant expertise to the company. Previously, he served as the Director of Market Research at Unchained, where he contributed to institutional Bitcoin adoption by providing collaborative custody solutions. He also held the position of Head Analyst at Blockware Solutions, where he helped launch one of the largest Bitcoin mining platforms in the United States. Burnett's expertise is expected to be instrumental in guiding Semler Scientific's Bitcoin treasury strategy and delivering long-term value to stockholders.
Semler Scientific's commitment to Bitcoin has not gone unnoticed by investors. The company's stock price has seen positive movement following announcements related to its Bitcoin strategy. The company reported a year-to-date BTC Yield of 26.7%. Since adopting the Bitcoin Standard in May 2024, Semler has "achieved approximately 287% BTC Yield and a $177 million BTC $ Gain through June 3, 2025".
While Semler Scientific's Bitcoin strategy has generated significant returns, it's essential to acknowledge the risks associated with investing in Bitcoin, including its price volatility and regulatory uncertainty. The company acknowledges these risks in its filings with the Securities and Exchange Commission. The company's success hinges on the continued rise in Bitcoin's price and the ability to manage the risks associated with its accumulation strategy.
Despite these risks, Semler Scientific's leadership remains confident in the long-term potential of Bitcoin and its ability to create value for shareholders. The company's bold move into Bitcoin has positioned it as a unique player in both the healthcare and financial sectors, attracting attention from investors and industry observers alike.
